MediciNova, Inc. (4875.T)

JPY 214.0

(0.47%)

Revenue Summary of MediciNova, Inc.

  • MediciNova, Inc.'s latest annual revenue in 2023 was 1 Million USD , down 0.0% from previous year.
  • MediciNova, Inc.'s latest quarterly revenue in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • MediciNova, Inc. reported a annual revenue of - USD in annual revenue 2022, down -100.0% from previous year.
  • MediciNova, Inc. reported a annual revenue of 4.03 Million USD in annual revenue 2021, down 0.0% from previous year.
  • MediciNova, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • MediciNova, Inc. reported a quarterly revenue of - USD for 2023 Q4, down -100.0% from previous quarter.

Annual Revenue Chart of MediciNova, Inc. (2023 - 2019)

Historical Annual Revenue of MediciNova, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 1 Million USD 0.0%
2022 - USD -100.0%
2021 4.03 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of MediciNova, Inc.

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY 99.979%
PRISM BioLab Co.,LTD 112.92 Million JPY 99.114%
GNI Group Ltd. 26.01 Billion JPY 99.996%
Linical Co., Ltd. 12.3 Billion JPY 99.992%
Trans Genic Inc. 13.08 Billion JPY 99.992%
MEDINET Co., Ltd. 661.54 Million JPY 99.849%
Soiken Holdings Inc. 5.15 Billion JPY 99.981%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY 99.936%
AnGes, Inc. 152.98 Million JPY 99.346%
OncoTherapy Science, Inc. 610.11 Million JPY 99.836%
Nxera Pharma Co., Ltd. 12.76 Billion JPY 99.992%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY 99.878%
NanoCarrier Co., Ltd. 135.5 Million JPY 99.262%
Carna Biosciences, Inc. 1.62 Billion JPY 99.938%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY 99.767%
RaQualia Pharma Inc. 1.9 Billion JPY 99.947%
Chiome Bioscience Inc. 682.46 Million JPY 99.853%
Kidswell Bio Corporation 2.43 Billion JPY 99.959%
PeptiDream Inc. 28.71 Billion JPY 99.997%
Oncolys BioPharma Inc. 63.03 Million JPY 98.414%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited - JPY -Infinity%
Healios K.K. 121 Million JPY 99.174%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY -1288.889%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY 97.493%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 4.51 Billion JPY 99.978%
FunPep Company Limited 530 Thousand JPY -88.679%
Kringle Pharma, Inc. 69.25 Million JPY 98.556%
Stella Pharma Corporation 269.49 Million JPY 99.629%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. 316.81 Million JPY 99.684%
Cuorips Inc. 23.1 Million JPY 95.671%
K Pharma,Inc. 1 Billion JPY 99.9%
Takara Bio Inc. 43.5 Billion JPY 99.998%
ReproCELL Incorporated 2.42 Billion JPY 99.959%
PhoenixBio Co., Ltd. 1.71 Billion JPY 99.942%
StemCell Institute Inc. 2.48 Billion JPY 99.96%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY 99.96%
CellSeed Inc. 190.13 Million JPY 99.474%